- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Targeting ferroptosis in melanoma: cancer therapeutics ; volume:21 ; number:1 ; day:23 ; month:11 ; year:2023 ; pages:1-16 ; date:12.2023
Cell communication and signaling ; 21, Heft 1 (23.11.2023), 1-16, 12.2023
- Urheber
-
Khorsandi, Khatereh
Esfahani, HomaSadat
Ghamsari, Saeedeh Keyvani-
lakhshehei, Parisa
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-023-01296-w
- URN
-
urn:nbn:de:101:1-2024021309104662658068
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Khorsandi, Khatereh
- Esfahani, HomaSadat
- Ghamsari, Saeedeh Keyvani-
- lakhshehei, Parisa
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Targeting ferroptosis in breast cancer
Targeting CDK9 for anti-cancer therapeutics
Melanoma : Biologically Targeted Therapeutics
miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma
Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1
Metabolic reprogramming and targeting ferroptosis in breast cancer
Novel insights on targeting ferroptosis in cancer therapy
Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
Targeting prominin2 transcription to overcome ferroptosis resistance in cancer
Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics
Developing novel specific therapeutics targeting adipocytes
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Targeting ferroptosis in breast cancer
Targeting CDK9 for anti-cancer therapeutics
Melanoma : Biologically Targeted Therapeutics
miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma
Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1
Metabolic reprogramming and targeting ferroptosis in breast cancer
Novel insights on targeting ferroptosis in cancer therapy
Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
Targeting prominin2 transcription to overcome ferroptosis resistance in cancer
Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics
Developing novel specific therapeutics targeting adipocytes
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Targeting ferroptosis in breast cancer
Targeting CDK9 for anti-cancer therapeutics
Melanoma : Biologically Targeted Therapeutics
miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma
Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1
Metabolic reprogramming and targeting ferroptosis in breast cancer
Novel insights on targeting ferroptosis in cancer therapy
Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
Targeting prominin2 transcription to overcome ferroptosis resistance in cancer
Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics